A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Chorionic gonadotropin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.